Safety of tranexamic acid in women with heavy menstrual bleeding: An open-label extension study

Women's Health

Volumn 7, Issue 5, 2011, Pages 591-598

  Lukes, Andrea S ^a   Freeman, Ellen W ^b   Van Drie, Douglas ^c   Baker, Jeffrey ^d   Adomako, Tammie L ^e  

^a Carolina Women's Research and Wellness Center   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c Female Pelvic Medicine and Urogynecology Institute of Michigan   (United States)

^d Rosemark WomenCare Specialists   (United States)

^e FERRING PHARMACEUTICALS   (United States)

Author keywords

competitive plasminogen inhibitor; heavy menstrual bleeding; menorrhagia; safety; tolerability; tranexamic acid

Indexed keywords

TRANEXAMIC ACID;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ADULT; ARTERY OCCLUSION; ARTHRALGIA; ARTICLE; BACKACHE; BLURRED VISION; BODY WEIGHT; BRAIN STEM INFARCTION; CARDIOVASCULAR DISEASE; CHALAZION; CLINICAL STUDY; COLOR VISION DEFECT; CONSTIPATION; CONTROLLED STUDY; CORNEA PIGMENTATION; DIARRHEA; DRUG DESIGN; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DRY EYE; DYSPEPSIA; DYSPNEA; ELECTROCARDIOGRAPHY; ENDOMETRIAL DISEASE; ENDOMETRIAL THICKNESS; EYE DISCHARGE; EYE DISEASE; EYE TOXICITY; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GYNECOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOTENSION; INFLUENZA; INTRACRANIAL ANEURYSM; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LIMB PAIN; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUATION DISORDER; MIGRAINE; MULTIPLE ALLERGIES; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL PAIN; NAUSEA; NECK PAIN; OCULAR PRURITUS; OPEN STUDY; OPHTHALMOLOGY; OVARY CYST; PHYSICAL DISABILITY; PIGMENT DISORDER; QT PROLONGATION; RETINA PIGMENTATION; RETINAL ARTERY STENOSIS; SALPINGITIS; SIDE EFFECT; SINUS CONGESTION; SINUS HEADACHE; SINUSITIS; ST WAVE; STOMACH CARCINOID; T WAVE; THROAT DISEASE; THROMBOEMBOLISM; TOOTH PAIN; TRIGEMINUS NEURALGIA; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; UTERUS MYOMA; VITAL SIGN; VOMITING;

ADOLESCENT; ADULT; ANTIFIBRINOLYTIC AGENTS; DOUBLE-BLIND METHOD; DRUG TOXICITY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MENORRHAGIA; MIDDLE AGED; TRANEXAMIC ACID; VISION TESTS; YOUNG ADULT;

EID: 80052448886     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.55     Document Type: Article

References (18)

1. Wathen PI, Henderson MC, Witz CA. Abnormal uterine bleeding. Med. Clin. North Am. 79(2), 329-344 (1995).
2. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 10(3), 183-194 (2007). (Pubitemid 46802276)
3. Shankar M, Chi C, Kadir RA. Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 14(1), 15-20 (2008).
4. Rybo G. Tranexamic acid therapy: effective treatment in heavy menstrual bleeding. Clinical update on safety. Ther. Adv. 4, 1-8 (1991).
5. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 57(6), 1005-1032 (1999). (Pubitemid 29313210)
6. Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 63(13), 1417-1433 (2003). (Pubitemid 36776096)
7. Moore KA, Morin I, Marenco T et al. Pharmacokinetic studies of women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding. Am. J. Ther. doi: 101097/MJT.0b013e318205427a (2011) (Epub ahead of print).
8. Freeman E.W.,Lukes A.,Van Drie D.,et al. A dose-response study of a novel tranexamic formulation for heavy menstrual bleeding, Am. J. Obstet. Gynecol. 2011 101016/j. ajog.201105015 Epub ahead of print)
9. Lukes A, Moore KA, Muse KN et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet. Gynecol. 116(4), 865-875 (2010).
10. Muse K, Gersten J, Waldbaum A, Mabey RG, Lukes A. Novel, oral tranexamic acid improves the general quality of life (SF-36™ Health Survey Measures) in women with menorrhagia. Presented at: American Society for Reproductive medicine 66th Annual Meeting. Denver, CO, USA 27 October 2010
11. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet. Gynecol. 85(6), 977-982 (1995).
12. Lukes AS, Kouides PA, Moore KA. Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding. Women's Health 7(2), 151-158 (2011).
13. Cravens GT, Brown MJ, Brown DR, Wass CT. Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: postoperative visual color changes after tranexamic acid administration. Anesthesiology 105(6), 1274-1276 (2006). (Pubitemid 44808593)
14. Sundstrom A, Seaman H, Kieler H, Alfredsson L. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. BJOG 116(1), 91-97 (2009).
15. Lindoff C, Rybo C, Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb. Haemost. 70(2), 238-240 (1993).
16. Molenaar IQ, Warnaar N, Groen H, TenVergert EM, Slooff MJH, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and metanalysis. Am. J. Transplant. 7(1), 185-194 (2007). (Pubitemid 44952872)
17. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 287(3), 337-344 (2002). (Pubitemid 34251967)
18. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst. Rev. 4, CD000400 (2007).